Epidemiology, etiology, and treatment of chronic leg ulcer: experience with sixty patients

Ann Afr Med. 2010 Jan-Mar;9(1):1-4. doi: 10.4103/1596-3519.62615.

Abstract

Background: Chronic leg ulcer (CLU) is reported to have an impact on virtually all aspects of life. Treatment is expensive and has large economic burden on many countries' health services. This presentation is to determine the impact, etiology, and presentation of CLU as well as the procedures for processing in a Nigeria tertiary care facility.

Methods: All patients with CLU seen that were prospectively managed in our hospital between 2004 and 2006 have been included in the study. The data were analyzed by SPSS version 11.0 of software.

Results: Sixty consecutive patients seen over a period of 3 years (2004-2006) were prospectively studied. There were two peak period of age presentation 30-39 and 50-69 years. The male female ratio was 1:1. Most of the patients (93.3%) had unilateral ulcers and it was as common on the right as on the left. Fifty percent of patients had medical disorders. The commonest cause of CLU was poorly managed traumatic wound.

Conclusion: Most patients benefited from debridement with or without split thickness skin graft or flap.

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Anti-Infective Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Chronic Disease
  • Debridement / methods
  • Female
  • Humans
  • Incidence
  • Infant
  • Infant, Newborn
  • Leg Ulcer / epidemiology*
  • Leg Ulcer / microbiology
  • Leg Ulcer / therapy*
  • Male
  • Middle Aged
  • Nigeria / epidemiology
  • Prospective Studies
  • Pseudomonas aeruginosa / isolation & purification
  • Skin Transplantation / methods
  • Staphylococcus aureus / isolation & purification
  • Surgical Wound Infection / diagnosis
  • Surgical Wound Infection / epidemiology*
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / therapy
  • Treatment Outcome
  • Wound Healing / drug effects*
  • Young Adult

Substances

  • Anti-Infective Agents